ISPOR - EE601 Using Dupilumab in Line With the England NICE Recommendation (TA534): Impact on the Healthcare Resource Utilization and Non-Medicine Cost

Full Text

EE601 Using Dupilumab in Line With the England NICE Recommendation (TA534): Impact on the Healthcare Resource Utilization and Non-Medicine Cost

Abstract

Authors

J Tavi K Noonan A Kuznik H Rashid R Hudson M Hodgson H Bouguerra

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now